Prosecution Insights
Last updated: April 19, 2026

Examiner: VANNI, GEORGE STEVEN

Tech Center 1600 • Art Units: 1631 1672 1686

This examiner grants 66% of resolved cases

Performance Statistics

66.4%
Allow Rate
+6.4% vs TC avg
623
Total Applications
+25.1%
Interview Lift
1519
Avg Prosecution Days
Based on 581 resolved cases, 2023–2026

Rejection Statute Breakdown

26.2%
§101 Eligibility
6.7%
§102 Novelty
25.4%
§103 Obviousness
13.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17970504 SEMICONDUCTOR-BASED BIOSENSORS FOR BASE CALLING Non-Final OA ILLUMINA, INC.
17284708 METHODS OF SCALING COMPUTATIONAL GENOMICS WITH SPECIALIZED ARCHITECTURES FOR HIGHLY PARALLELIZED COMPUTATIONS AND USES THEREOF Non-Final OA PRESIDENT AND FELLOWS OF HARVARD COLLEGE
17033218 METHODS AND SYSTEMS FOR ASSOCIATING PHYSICAL AND GENETIC PROPERTIES OF BIOLOGICAL PARTICLES Non-Final OA 10X Genomics, Inc.
17368389 BIOLOGICAL INFORMATION DETECTION DEVICE Non-Final OA DENSO CORPORATION
19273028 GENERATIVE PROTEIN DESIGN WITH COMPOSABLE ENERGY-BASED MODELS Final Rejection Hoffmann-La Roche, Inc.
17273262 Method for Quantitative Evaluation of Protein Domains in Human Tissue for Diagnostic and Therapeutic Applications Non-Final OA KONICA MINOLTA INC.
17764145 MULTIDIMENSIONAL MICROFLUIDIC PROTEIN CHARACTERISATION Non-Final OA Cambridge Enterprise Limited
19171081 SYSTEMS AND METHODS FOR EVALUATING TUMOR FRACTION Non-Final OA Foundation Medicine, Inc.
17801687 EFFICIENCY INFERENCE APPARATUS Non-Final OA DAIKIN INDUSTRIES, LTD.
19053053 SYSTEMS AND METHODS FOR NUTRIGENOMICS AND NUTRIGENETIC ANALYSIS Final Rejection Cipher Genetics, Inc.
17744536 Identification of Host RNA Biomarkers of Infection Non-Final OA The Regents of the University of Colorado, a Body Corporate
17785300 GENOMIC SCARRING ASSAYS AND RELATED METHODS Non-Final OA Agilent Technologies, Inc.
18514319 RELATIONAL BIOMARKERS THAT DISTINGUISH DISEASES AND DISORDERS FROM CONTROLS AND USES THEREOF TO PREDICT PATHOPHYSIOLOGICAL OUTCOMES Final Rejection Signature Diagnostics Inc.
17104099 CLASSIFYING SEIZURES AS EPILEPTIC OR NON-EPILEPTIC USING EXTRA-CEREBRAL BODY DATA Final Rejection FLINT HILLS SCIENTIFIC, LLC
16986831 IMMUNE RECOGNITION MOTIFS Non-Final OA IOGENETICS, LLC
17111444 SECURE COMMUNICATION OF NUCLEIC ACID SEQUENCE INFORMATION THROUGH A NETWORK Non-Final OA Cipherome, Inc.
18138207 METHODS FOR PREDICTING PROSTATE CANCER AND USES THEREOF Non-Final OA miR Scientific, LLC
18003535 METHODS FOR PREDICTING THE RISK OF RECURRENCE AND/OR DEATH OF PATIENTS SUFFERING FROM A SOLID CANCER AFTER PREOPERATIVE ADJUVANT THERAPIES Non-Final OA UNIVERSITÉ DE PARIS
18001544 METHOD FOR CALCULATING THE FIDELITY OF THE SIGNAL OF POLYMORPHIC GENETIC LOCI Non-Final OA seeDNA Inc.
17162643 THREE-DIMENSIONAL MODELING OF PATIENT-SPECIFIC TUMORS USING A LATTICE OF ELASTIC-MATERIAL POINTS Non-Final OA SimBioSys, Inc.
17130304 SYSTEMS AND METHODS FOR MONITORING OF BLOOD LACTATE AND TARGETING OF BLOOD LACTATE VIA NUTRITIONAL SUPPORT Non-Final OA Run Them Sweet LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month